Perrigo | PRGO - Equity Capital And Reserves


Perrigo reported $2.94B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Abbott USD 52.13B 1.3B Dec/2025
Bayer EUR 25.95B 3.75B Dec/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Coherus Biosciences USD 61.01M 26.76M Dec/2025
Corcept Therapeutics USD 647.8M 15.9M Dec/2025
Dr.Reddys Laboratories INR 375.76B 13.67B Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
J&J USD 81.19B 358M Mar/2026
Merck USD 51.85B 2.79B Sep/2025
Nestle CHF 32.81B 3.98B Dec/2025
Pacira USD 693.11M 34.1M Dec/2025
Perrigo USD 2.94B 1.51B Dec/2025
Pfizer USD 92.8B 4.11B Sep/2025
Phibro Animal Health USD 332.36M 20.68M Dec/2025
Prestige Brands USD 1.83B 4.48M Dec/2025
Reckitt Benckiser GBP 6.7B 1.39B Dec/2024
Sanofi EUR 72.81B 1.1B Mar/2026
Supernus Pharmaceuticals USD 1.06B 12.05M Dec/2025
Teva Pharmaceutical Industries USD 7.91B 664M Dec/2025
Xeris Pharmaceuticals USD 13.69M 14.55M Dec/2025
Zoetis USD 3.33B 2.07B Dec/2025